To Evaluate Whether Acetyl Salicylic Acid (Aspirin), the Combination of Aspirin and Clopidogrel and Darexaban (YM150) Interact in Their Effects

Clinical trial NCT01409616 · COMPLETED

Trial details

NCT number: NCT01409616
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacodynamic Interaction Healthy Subjects

Start date: 2009-04-01
Primary completion: 2009-09-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.